James C. Blair, Director at Clovis Oncology, Inc. (CLVS), sold 27,056 shares at $27.79 ($474K) on 2019-03-14, disclosed to the SEC on 2019-03-18.
Open-market sale of $474k CLVS by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.79 | 17,056 | $474K | 100.0% |
| 2 | $0.00 | 10,000 | $0 | 0.0% |
| Total | $17.52 avg | 27,056 | $474K | 100% |
| Filing → |
| CLVS | SELL | 2017-08-08 | $2.9M | — | Filing → |
| EVOK | SELL | 2016-05-27 | $1.6M | — | Filing → |
| EVOK | SELL | 2016-04-08 | $5K | — | Filing → |